Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population Pharmacokinetics of Levofloxacin in Severe Community-Acquired Pneumonia
NCT02018081Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in community acquired pneumonia (CAP), sponsored by Centre hospitalier universitaire de Toulouse. Started Mar 2012; status: completed.
02
Drugs
levofloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT02018081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018081.